What this story covers

Eastman Chemical's Q3 2025 10-Q shows a 5% nine-month revenue drop to $6.779 billion amid weak demand in construction and industrials, with gross margins contracting to 22.2%. Adjusted EBIT held at $796 million via cost savings. Segments varied: AFP resilient with pricing gains, others hit by volumes. Strategy emphasizes molecular recycling and R&D up 7%, liquidity solid with $489 million cash despite capex. Risks include economic volatility and environmental liabilities estimated at $322 million reserved.

Story snapshot